NücleoGenex Announces Exclusive Licensing Agreement for Panoxol, a Patented Nutraceutical Supplement
DALLAS, May 1, 2023 (Newswire.com)
–
NücleoGenex, a company supplying DNA-based personalized nutrition, has announced an exclusive license agreement wit…
The post NücleoGenex Announces Exclusive Licensing Agreement for Panoxol, a Patented Nutraceutical Supplement first appeared on RSVTV news.
HelloPrenup & the Knot Promote Prenups in ‘Get the Prenup’
The Knot, a leading wedding publication, featured the premier prenuptial agreement platform, HelloPrenup, to propose the importance of prenups when entering into marriage.
BOSTON, May 1, 2023 (Newswire.com)
–
The informative series, “Get the Prenup,” written by Deputy Editor, Esther Lee, in The Knot Magazine Summer 2023 Inspiration Issue, with designed illustrations by Abby McCartin, gets on one knee about the benefits of prenuptial agreements and how at minimum, a prenup can encourage communication before entering marriage.
Prenuptial agreements by nature are designed to be a wealth planning tool and act as a key resource for getting on the same page financially as their partner.
“While each marriage differs, a solid prenup unifies couples in at least one respect: It encourages communication as you prepare for marriage…With contractual services available online, there’s little reason not to discuss your financial solution with your partner. Trust us: Sign the prenup before the marriage license.” – Esther Lee, Deputy Editor, The Knot
Though prenups have traditionally been seen as “taboo” or “unromantic,” there’s an increasing shift in prenup perceptions among millennials and Gen-Zers and how the benefits mitigate potential risks encountered prior to getting into a legally binding contract.
“Our data found that 46% of couples describe prenups as ‘smart,’ while another 20 percent perceived these contracts to be ‘cynical,” says Lee.
Featured within the article is Julia Rodgers, the Chief Prenup Officer and CEO of HelloPrenup—the online prenuptial agreement platform for affordable, timely, and collaborative prenups. Traditionally, the prenuptial agreement process was sought through billable attorney hours, lengthy contract negotiations, and relatively adversarial conversations between partners and their counsel. Within the article, she gives examples of how states view money as a married couple and what to consider when discussing the couple’s future.
“Without a prenuptial agreement, in most states, monetary gifts received during the marriage will be considered marital property. A prenup allows couples to decide if they would like these monetary gifts to be considered separate property.” — Julia Rodgers, CEO & co-founder, HelloPrenup
HelloPrenup’s mission is to get every couple the legal protection they need without spending thousands of hours or dollars on prioritizing their financial future before entering one of the most exciting times of their lives.
HelloPrenup has been featured on Shark Tank, CNN Business, Forbes, The Boston Globe, GeekWire, and The New Yorker, among others. Want more information on Julia or HelloPrenup? Contact [email protected] or visit HelloPrenup.com to learn more.
Contact Information:
Lauren Lavender
Chief Marketing Officer
408 476 0719
Original Source:
HelloPrenup & the Knot Promote Prenups in ‘Get the Prenup’
The post HelloPrenup & the Knot Promote Prenups in ‘Get the Prenup’ first appeared on RSVTV news.
Ursuline College Adds New Nurse Anesthesia Program Through Innovative Corporate Collaboration
PEPPER PIKE, Ohio, May 1, 2023 (Newswire.com)
–
Ursuline College announces the addition of a nurse anesthesia specialty to its Doctor of Nursing Practic…
Biolage Professional Adds Aloe- and Hyaluronic Acid-Infused Blow Dry Shaping Lotion to Its Cult-Favorite Hydra Source Collection
The new vegan, cruelty-free Hydra Source Blow Dry Shaping Lotion is infused with aloe vera, hyaluronic acid and styling polymers for weightless conditioning, heat protection and shape-memory to extend your hairstyles.
…
The post Biolage Professional Adds Aloe- and Hyaluronic Acid-Infused Blow Dry Shaping Lotion to Its Cult-Favorite Hydra Source Collection first appeared on NT Beauty.
OLA GOLD BEAUTY — The Natural, Vegan and Melanin-Approved Personal Care and Skincare Line Has Taken the Market by Storm
OLA GOLD BEAUTY’s April Launch Sold Out in Record Time, Prompting the Company to Introduce More New Products to Its Customers May 1
DALLAS, May 1, 2023 (Newswire.com)
–
Introducing OLA GOLD BEAUTY — the natural, vegan, and melanin-approved personal care and skincare line that has taken the market by storm. Created by Daisha Agboola, formerly known as Daisha Collins, OLA GOLD BEAUTY has quickly become a go-to brand for those seeking high-quality, natural, and nourishing products for their skin and body.
Agboola’s journey began in college during the COVID-19 lockdown of 2020 when she realized that most dermatologists were not accepting appointments due to the pandemic. As a result, she turned to store-bought products to take care of her skin, but she soon discovered that they were not effective for melanin skin. Her husband’s dermatitis condition worsened with the use of store-bought products, and this led her to research the ingredients used in these products.
After realizing that many beauty products on the market contain cancerous ingredients, harsh chemicals, parabens, phthalates, and sulfates, Agboola decided to take matters into her own hands. She began creating her own herbal and vitamin-infused products from scratch, using natural and nourishing ingredients that she knew were safe for her skin and body. She started producing the products in her kitchen and before long, her friends and family began to notice the difference in her skin’s health and appearance.
Fast forward to January 2021, and OLA GOLD BEAUTY was born. The brand offers a range of natural and luxurious personal care products that provide the skin and body with nutrients, natural herbs, and vitamins, delivering moisture, hydration, improvement, and added protection. The products are free from petroleum, formaldehydes, harsh chemicals, parabens, phthalates, and sulfates, making them a safe and healthy choice for all skin types.
OLA GOLD BEAUTY has quickly become a fan-favorite, with last month’s launch selling out in record time. The brand has been restocking and is introducing even more products today, May 1, 2023. By using OLA GOLD BEAUTY products, customers can enjoy a safer, more beneficial, and healthier personal care routine without putting their health at risk.
Daisha Agboola, the creator of OLA GOLD BEAUTY, is a true inspiration for those looking to pursue their dreams and make a difference in the world. Her passion for natural and safe personal care products has led her to create a brand that is not only good for the skin but good for the planet, too. Give OLA GOLD BEAUTY a try and discover the wonders of natural and nourishing skin care today.
Contact Information:
Daisha Agboola
Founder
Related Files
IMG_6083.JPG
IMG_6081.JPG
Original Source:
OLA GOLD BEAUTY — The Natural, Vegan and Melanin-Approved Personal Care and Skincare Line Has Taken the Market by Storm
The post OLA GOLD BEAUTY — The Natural, Vegan and Melanin-Approved Personal Care and Skincare Line Has Taken the Market by Storm first appeared on NT Beauty.
The Most Expensive reality show takes viewers on a journey through designer Debbie Wingham’s roots
In the upcoming fourth episode of the series, Debbie Wingham’s hometown in South Yorkshire is explored alongside her glamorous jet-set lifestyle in Dubai and Spain. Gossip Stone TV’s hit series, The Most Expensive with Debbie Wingham, is back with a brand-new episode that promises to take viewers on a wild adventure. In this fourth installment, […]
The post The Most Expensive reality show takes viewers on a journey through designer Debbie Wingham’s roots first appeared on RSVTV news.
As Baseball Season Begins With New Rules, ZetrOZ Systems’ sam Technology is Critical for Mitigating Injury Risk
Studies show hamstring and UCL injuries are most common in opening weeks, and sustained acoustic medicine is effective treatment for those soft-tissue injuries.
TRUMBULL, Conn., April 28, 2023 (Newswire.com)
–
Baseball is back, which means balls and strikes, hits and homers – and hamstring injuries. Studies show baseball’s most common injury, hamstring tendon tears, is more prevalent in the season’s first weeks, as is a common elbow injury. And this spring, both could become more frequent as rule changes reduce players’ recovery time between pitches and plays. One way to mitigate the risks of these injuries is ZetrOz Systems’ sustained acoustic medicine sam® device, which effectively treats soft-tissue injuries and can help players stay on the diamond.
The ZetrOZ sam® X1 and 2.0 devices are the only FDA-cleared wearable ultrasound units approved for daily home use. The low-intensity, long-duration ultrasound technology expedites the injury healing process without invasive surgery or potentially addictive painkillers and is clinically proven by more than 40 studies to reduce pain and improve function.
“We work with medical professionals nationwide, from orthopedic surgeons to athletic trainers, and they have used sam® to successfully treat thousands of professional and amateur athletes,” said Dr. George Lewis, founder and CEO of ZetrOZ Systems. “We know those injuries are more likely to occur at the start of a season, especially in baseball, and our technology can help mitigate risk and improve healing of those injuries.”
Several studies document the prevalence of injuries early in a season. A 2019 study in The Orthopaedic Journal of Sports Medicine used six years of Major League Baseball’s own injury tracking database to examine trends in hamstring injuries, which it found was the most common injury in baseball.
“In various professional sports leagues (NFL, NBA, MLB), hamstring strains have been found to occur earlier in the season. Our study found similar results, with the highest number of hamstring sprains in April and May,” the authors reported. “These factors may have an association with poor conditioning at the start of the season.”
About 40 percent of hamstring injuries occur in April and May, the analysis found. The rate of hamstring strains in Major League Baseball increased from one injury every 39 games in 2011 to one in every 30 games in 2016, with a similar trend in minor league baseball.
The pattern was the same in injuries to the elbow’s ulnar collateral ligament (UCL), according to a 2021 report from the Journal of Shoulder and Elbow Surgery, with April and May as peak months for UCL injuries. They also found that injuries within the first 90 days of the season were more severe, more commonly requiring surgery to repair them.
“Throwing athletes may have increased risk for an elbow injury at the start of the season because they have not attained midseason levels of muscle strength and endurance,” the authors wrote. They also found that pitchers’ shoulders had less range of motion early in the season, likely making them more vulnerable to injury.
Some observers fear injuries will be more common this year, with Major League Baseball now using a pitch clock that requires pitchers to throw to the batter within 15 seconds, or 20 seconds with a runner on base. That means pitchers have less recovery time between pitches, and batters have less recovery from swings or from running out foul balls.
A 2016 study in the Journal of Sports Science modeled the effects of the shorter rest period on pitching. The authors found that players would have more fatigue in the forearm muscles that stabilize the elbow, “increasing strain on the ulnar collateral ligament (UCL) and possibly increasing injury risk.”
Treatment with ZetrOZ’s sam® technology effectively treats injuries to tendons of the leg, elbow and other areas of the body. Among many studies demonstrating the system’s efficacy, a 2015 level 4 clinical study by sports medicine experts at The Ohio State University and Duke University found sustained acoustic medicine delivered via ZetrOZ’s sam® reduced pain and improved strength in patients’ medial/lateral elbow tendons and Achilles’ tendons.
Sustained acoustic medicine works by increasing blood vessel diameters to improve blood flow. That increases oxygenated hemoglobin at the site of the therapy and removes cytokine enzymes and cellular waste, with a result of more rapid healing and reduced pain.
“We know from our relationships with trainers across professional and college sports, as well physicians treating recreational athletes, that sam® heals athletes’ soft-tissue injuries more rapidly and helps players stay on the field or return to it more quickly,” Lewis said. “As baseball season begins and teams adapt to this new environment, sam® is available to help players stay healthy and on the diamond doing what they love.”
ZetrOZ Systems’ sam® technology was developed in part with funding from the National Institute of Health, National Science Foundation, Department of Defense and NASA. ZetrOZ Systems products are designed and manufactured in the United States and are protected by 46 U.S. patents.
To learn more, visit www.samrecover.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of the sam® product line, which is designed for the treatment of acute and chronic musculoskeletal conditions.
Contact Information:
Maria Penaloza
Original Source:
As Baseball Season Begins With New Rules, ZetrOZ Systems’ sam Technology is Critical for Mitigating Injury Risk
OFW Law Adds Team From Benjamin England & Associates
WASHINGTON, April 28, 2023 (Newswire.com)
–
Two of the nation’s premier firms focusing on food, drugs, agriculture, and medical device clients are joini…
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
ANKARA, Turkey & CONSHOHOCKEN, Penn., April 28, 2023 (Newswire.com)
–
Digital health start-up h2o Therapeutics today announced a collaboration with global healthcare company AmerisourceBergen to support the commercialization of Parky, a prescription mobile app cleared by the U.S. Food and Drug Administration (FDA) for monitoring certain symptoms in adults with Parkinson’s Disease.
The Parky app, which is compatible with the Movement Disorder API developed by Apple Inc., monitors symptoms such as tremors and dyskinesia in real time via the use of Apple Inc.’s Apple Watch. It is a direct-to-patient tool for sharing meaningful and reliable data between patients and medical professionals regarding the course of the disease. As part of a pilot arrangement, AmerisourceBergen will facilitate patient engagement and health system integration services as part of its DTx Connect solution.
“Following the recent FDA clearance, we continue to focus on strategies and solutions that will enable us to expand patient access to Parky,” said Yagmur Selin Gulmus, the founder of h2o Therapeutics. “Through this arrangement with AmerisourceBergen, our goal is to reduce barriers along the patient journey, improve access and expand our commercial reach. In support of the Parkinson’s Disease community, we are proud to launch our patient-oriented technology during Parkinson’s Awareness Month.”
“Digital therapeutics offer tremendous potential, but developers face unique challenges that can affect market access and product potential,” said Alex Kilgore, PharmD, Product Manager, Global Products and Solutions at AmerisourceBergen. “We look forward to supporting h2o Therapeutics and will leverage our digital health capabilities to help patients start on the Parky app following a prescription.”
Parkinson’s Disease, the fastest-growing neurological disorder, affects more than 10 million people worldwide, including about one million people in the United States, according to the Parkinson’s Foundation. The Parky App aims to help healthcare providers develop a profile of the patient in daily life, bridging the gap between real-life and in-clinic settings.
AmerisourceBergen offers a wide range of services to support DTx developers and biopharmaceutical companies across the commercialization journey, including market access consulting, distribution and patient support services. The company in 2022 announced its plans to develop and launch DTx Connect, a cloud-based, fully integrated ordering, dispensing, and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and digital diagnostics.
“During Parkinson’s Awareness Month, AmerisourceBergen could not be prouder to stand together with Parkinson’s Disease patients, their families and healthcare providers, and innovative digital health technology developers like h2o Therapeutics to support the best patient care,” said Jason Dinger, Senior Vice President of Global Products and Solutions at AmerisourceBergen.
About h2o Therapeutics
h2o Therapeutics is developing digital therapeutics with a focus on wearable technologies, Augmented Reality (AR), and Artificial Intelligence (AI). h2o intends to make real-time human data become a handy tool for disease management in certain therapeutic areas. Our core understanding of digital therapeutics lies in the power of AI, the robustness of their clinical health research, and high levels of user engagement. Parky, a Parkinson’s Disease prescription mobile app, received 510(k) clearance from the FDA in 2022.
About AmerisourceBergen
AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com.
Contact Information:
Yagmur Selin Gulmus
Founder
Hande Erciyes
Operations Manager
Original Source:
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
ANKARA, Turkey & CONSHOHOCKEN, Penn., April 28, 2023 (Newswire.com)
–
Digital health start-up h2o Therapeutics today announced a collaboration with global healthcare company AmerisourceBergen to support the commercialization of Parky, a prescription mobile app cleared by the U.S. Food and Drug Administration (FDA) for monitoring certain symptoms in adults with Parkinson’s Disease.
The Parky app, which is compatible with the Movement Disorder API developed by Apple Inc., monitors symptoms such as tremors and dyskinesia in real time via the use of Apple Inc.’s Apple Watch. It is a direct-to-patient tool for sharing meaningful and reliable data between patients and medical professionals regarding the course of the disease. As part of a pilot arrangement, AmerisourceBergen will facilitate patient engagement and health system integration services as part of its DTx Connect solution.
“Following the recent FDA clearance, we continue to focus on strategies and solutions that will enable us to expand patient access to Parky,” said Yagmur Selin Gulmus, the founder of h2o Therapeutics. “Through this arrangement with AmerisourceBergen, our goal is to reduce barriers along the patient journey, improve access and expand our commercial reach. In support of the Parkinson’s Disease community, we are proud to launch our patient-oriented technology during Parkinson’s Awareness Month.”
“Digital therapeutics offer tremendous potential, but developers face unique challenges that can affect market access and product potential,” said Alex Kilgore, PharmD, Product Manager, Global Products and Solutions at AmerisourceBergen. “We look forward to supporting h2o Therapeutics and will leverage our digital health capabilities to help patients start on the Parky app following a prescription.”
Parkinson’s Disease, the fastest-growing neurological disorder, affects more than 10 million people worldwide, including about one million people in the United States, according to the Parkinson’s Foundation. The Parky App aims to help healthcare providers develop a profile of the patient in daily life, bridging the gap between real-life and in-clinic settings.
AmerisourceBergen offers a wide range of services to support DTx developers and biopharmaceutical companies across the commercialization journey, including market access consulting, distribution and patient support services. The company in 2022 announced its plans to develop and launch DTx Connect, a cloud-based, fully integrated ordering, dispensing, and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and digital diagnostics.
“During Parkinson’s Awareness Month, AmerisourceBergen could not be prouder to stand together with Parkinson’s Disease patients, their families and healthcare providers, and innovative digital health technology developers like h2o Therapeutics to support the best patient care,” said Jason Dinger, Senior Vice President of Global Products and Solutions at AmerisourceBergen.
About h2o Therapeutics
h2o Therapeutics is developing digital therapeutics with a focus on wearable technologies, Augmented Reality (AR), and Artificial Intelligence (AI). h2o intends to make real-time human data become a handy tool for disease management in certain therapeutic areas. Our core understanding of digital therapeutics lies in the power of AI, the robustness of their clinical health research, and high levels of user engagement. Parky, a Parkinson’s Disease prescription mobile app, received 510(k) clearance from the FDA in 2022.
About AmerisourceBergen
AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com.
Contact Information:
Yagmur Selin Gulmus
Founder
Hande Erciyes
Operations Manager
Original Source:
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease